In the hopes of building upon recent research into oncology pharmacy practice workload and productivity, the Hematology/Oncology Pharmacist Association (HOPA) conducted a survey aiming to assess task valuation.

In order to pursue this goal, HOPA deployed a brief web-based survey across early 2025 to eligible oncology pharmacists. After gathering responses, tasks were assessed in terms of those most valued and those most associated with lower job satisfaction.

The results of the survey not only identify tasks highly valued by oncology pharmacists, but help paint a fuller picture of day-to-day life in the oncology pharmacy workforce, with both its rewards and challenges. The overarching objective is that identifying these valued tasks and workforce challenges can aid in future strategic decision-making, emphasize higher-valued services, enhance job satisfaction, and improve retention in the field.

The full methods and results were published in the Journal of Oncology Pharmacy Practice.


Authors: Lydia L. Benitez, Jessie Signorelli, Kristin Adler, Sarah Cimino, Julianne Darling, Emily Dotson, Joshua A. Goodner, Christy Harris, Rachel L. McDevitt, Brendan Rasor, Bridgette Kanz Schroader, Marie Sirek, Vishnuprabha Vogel, Alexandra S. Wolff, and Shawn P. Griffin

Read the abstract and full article here

A photo of several HOPA members posing in front of the Capitol
Advocacy

HOPA Hill Day 2026 Reaches New Milestones with Advocacy Efforts in D.C.

A record-topping number of participants united in Washington D.C. for HOPA In-Person Hill Day, bringing today’s pressing cancer care concerns and constructive policy conversations to the Capitol.

Advocacy

End Cancer Drug Shortages Coalition: A Consensus Statement on Drug Shortages

HOPA has spearheaded a multi-year initiative with 16 other organizations to establish the consensus for combating cancer drug shortages. The statement outlines the major factors contributing to this crisis, and recommends policy solutions.

HOPA logo
Advocacy

HOPA Issues Updated Drug Shortages Brief

Shortages of drugs that are essential for the treatment and care of individuals with cancer result in compromises to patient care and, ultimately, outcomes.